Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MET D1228V
i
Other names:
DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4233
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MET overexpression (32)
MET expression (12)
MET positive (8)
EGFR expression + MET expression (2)
MET overexpression + KDR overexpression (2)
MET overexpression + SYK overexpression (2)
TPBG expression + MET expression (2)
FGFR overexpression + MET overexpression (1)
MET expression + HER-2 expression (1)
MET overexpression + HER-2 overexpression (1)
MET overexpression + MUC5B overexpression (1)
MET underexpression (1)
PTGS2 positive + MET positive + TOPK positive + EGFR mutation (0)
MET overexpression (32)
MET expression (12)
MET positive (8)
EGFR expression + MET expression (2)
MET overexpression + KDR overexpression (2)
MET overexpression + SYK overexpression (2)
TPBG expression + MET expression (2)
FGFR overexpression + MET overexpression (1)
MET expression + HER-2 expression (1)
MET overexpression + HER-2 overexpression (1)
MET overexpression + MUC5B overexpression (1)
MET underexpression (1)
PTGS2 positive + MET positive + TOPK positive + EGFR mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MET D1228V
Non Small Cell Lung Cancer
MET D1228V
Non Small Cell Lung Cancer
erlotinib + cabozantinib capsule
Sensitive: C4 – Case Studies
erlotinib + cabozantinib capsule
Sensitive
:
C4
erlotinib + cabozantinib capsule
Sensitive: C4 – Case Studies
erlotinib + cabozantinib capsule
Sensitive
:
C4
MET D1228V
Non Small Cell Lung Cancer
MET D1228V
Non Small Cell Lung Cancer
osimertinib + savolitinib
Sensitive: C4 – Case Studies
osimertinib + savolitinib
Sensitive
:
C4
osimertinib + savolitinib
Sensitive: C4 – Case Studies
osimertinib + savolitinib
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login